Follitropin Alfa

Introduction

Follitropin alfa is a recombinant form of follicle-stimulating hormone (FSH), used in fertility treatments. It mimics the natural hormone FSH, which is essential for reproductive processes in both men and women. This medication is commonly used in assisted reproductive technologies such as in vitro fertilization (IVF).

Uses

Follitropin alfa is primarily used for:

Stimulation of ovarian follicle development in women undergoing assisted reproductive technologies (ART) such as IVF or intrauterine insemination (IUI).
Treatment of hypogonadotropic hypogonadism in men, a condition where the testes fail to produce sperm due to inadequate stimulation from FSH.

Brand Name	Follitropin Alfa
Type
Weight
Generic	Follitropin Alfa
Manufacturer
Available in	English বাংলা

Mechanism of Action

Follitropin alfa works by stimulating the ovarian follicles in women and the Sertoli cells in men, which in turn promotes the production of eggs and sperm, respectively. It mimics the action of naturally occurring FSH, leading to the development of ovarian follicles and increased fertility.

How Long Does It Take to Work?

The effects of follitropin alfa can be observed within a few weeks of starting treatment. In women, follicular response to FSH usually becomes noticeable after about 7 to 14 days of administration. For men, improvements in sperm production may take several months.

Absorption

Follitropin alfa is administered via subcutaneous injection, which allows for direct absorption into the bloodstream. The bioavailability of the drug is high due to its administration route.

Route of Elimination

The drug is primarily eliminated through the liver and kidneys. It undergoes proteolytic cleavage and other metabolic processes before being excreted in the urine.

Dosage

Female infertility: Dose should be individualised. Recommended initial: 75 IU/day; may increase by up to 37.5 IU after 14 days; further increases of the same magnitude may be made every 7 days, if needed. Max: 300 IU/day. If response is appropriate, administer hCG 1 day after the last dose.

Assisted reproductive technologies Initial: 150-225 IU/day for at least 4 days, to be started on day 2 or 3 of cycle, until follicular development is adequate. Adjust dose based on ovarian response. Usual max: 450 IU/day. Once follicular development is adequate, administer hCG to induce final follicular maturation. Withhold hCG if ovaries are abnormally enlarged.

Spermatogenesis induction 150 IU 3 times/week with continued chorionic gonadotrophin for at least 4 mth. Max: 300 IU 3 times/week

The dosage of follitropin alfa varies depending on the patient's condition and response to treatment:

For women undergoing ART: Initial doses are typically 75 to 150 IU daily, adjusted based on ovarian response as monitored by ultrasound and hormone levels.
For men with hypogonadotropic hypogonadism: The dosage can vary, but a common regimen is 150 IU three times a week.

Dosage should be tailored to the individual patient's needs and treatment goals.

Administration

Follitropin alfa is administered via subcutaneous injection. Patients are often trained to self-administer the medication at home. The injection site should be rotated to minimize irritation.

Side Effects

Common side effects include:

Headache.
Abdominal pain.
Ovarian hyperstimulation syndrome (OHSS), which can cause abdominal swelling, pain, and discomfort.
Injection site reactions such as redness or swelling.

Serious side effects, though less common, may include severe OHSS or allergic reactions.

Toxicity

Toxicity is rare but may occur with overdose or excessive stimulation. Symptoms of toxicity can include severe abdominal pain, ascites, or signs of OHSS. Immediate medical consultation is necessary if these symptoms arise.

Precautions

Precautions include:

Monitoring for signs of OHSS, especially with higher doses.
Regular ultrasounds and blood tests to monitor ovarian response in women.
Use with caution in patients with a history of ovarian cysts or other reproductive issues.

Interaction

Drug interactions with follitropin alfa are generally minimal. However, interactions with other fertility medications or hormonal treatments should be monitored to avoid potential effects on the treatment outcome.

Disease Interaction

Follitropin alfa should be used with caution in patients with conditions affecting ovarian function or those with a history of ovarian hyperstimulation syndrome.

Drug Interaction

Potential drug interactions include:

Other hormonal therapies that may affect the efficacy of follitropin alfa or increase the risk of OHSS.
Drugs affecting liver or kidney function that may alter drug metabolism and clearance.

Food Interactions

There are no specific food interactions with follitropin alfa. It can be used regardless of food intake, but patients should follow any specific dietary recommendations provided by their healthcare provider.

Pregnancy Use

Follitropin alfa is not used during pregnancy. It is intended for use prior to conception to aid in fertility. If pregnancy occurs during treatment, the medication should be discontinued.

Lactation Use

The effects of follitropin alfa during lactation are not well-studied. It is generally recommended to consult with a healthcare provider before using the drug while breastfeeding.

Acute Overdose

In the case of acute overdose, symptoms may include severe ovarian hyperstimulation syndrome. Treatment involves discontinuing the medication and providing supportive care. Immediate medical attention is required.

Contraindication

Follitropin alfa is contraindicated in individuals with:

Primary ovarian insufficiency.
Uncontrolled thyroid or adrenal dysfunction.
Hormone-sensitive cancers or known hypersensitivity to follitropin alfa or any of its components.

Use Direction

Follow the prescribed dosage and administration instructions provided by your healthcare provider. Adhere to the monitoring schedule and report any side effects or adverse reactions promptly.

Storage Conditions

Store follitropin alfa in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the medication in its original packaging to protect it from light.

Volume of Distribution

The volume of distribution for follitropin alfa is not well-documented but is generally assumed to be limited to the vascular and interstitial spaces due to its large molecular size.

Half Life

The half-life of follitropin alfa is approximately 13 to 20 hours. The drug is typically administered daily or as needed based on individual treatment plans.

Clearance

Follitropin alfa is primarily cleared through the liver and kidneys. The clearance rate can be influenced by liver and renal function, requiring dose adjustments in patients with impaired function.

See in details version Follitropin Alfa also Follitropin Alfa in bangla